Natixis Advisors, L.P.
- SEC CIK
- 0001018331
- Latest filing
- Aug 14, 2026
AVNS holding history
Avanos Medical, Inc. in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVNS overviewAll 13F holders of AVNSFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,482
- Value
- $260.0K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,482 | $260.0K | <0.1% | +10,482 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −20,903−100.0% | Sold out | Holders |
| Q3 2025 | 20,903 | $242.0K | <0.1% | −31,984−60.5% | Reduced | Holders |
| Q2 2025 | 52,887 | $647.0K | <0.1% | +33,163+168.1% | Added | Holders |
| Q1 2025 | 19,724 | $283.0K | <0.1% | −6,220−24.0% | Reduced | Holders |
| Q4 2024 | 25,944 | $413.0K | <0.1% | +4,492+20.9% | Added | Holders |
| Q3 2024 | 21,452 | $515.0K | <0.1% | +2,574+13.6% | Added | Holders |
| Q2 2024 | 18,878 | $376.0K | <0.1% | +3,077+19.5% | Added | Holders |
| Q1 2024 | 15,801 | $315.0K | <0.1% | +1,659+11.7% | Added | Holders |
| Q4 2023 | 14,142 | $317.0K | <0.1% | +14,142 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −18,217−100.0% | Sold out | Holders |
| Q2 2023 | 18,217 | $466.0K | <0.1% | +2,877+18.8% | Added | Holders |
| Q1 2023 | 15,340 | $456.0K | <0.1% | +1,721+12.6% | Added | Holders |
| Q4 2022 | 13,619 | $369.0K | <0.1% | +13,619 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −11,287−100.0% | Sold out | Holders |
| Q1 2022 | 11,287 | $378.0K | <0.1% | +11,287 | New | Holders |